Home・Aandelen Lijst・ANI Pharmaceuticals Inc

ANI Pharmaceuticals Inc

Open

SectorGezondheidszorg

79.09 -0.63

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

77.72

Max

80.16

Belangrijke statistieken
By Trading Economics
Inkomsten	-61K 27M
Verkoop	-9.6M 237M
K/W Sectorgemiddelde	20.044 64.641
EPS	1.68
Winstmarge	11.551
Werknemers	970
EBITDA	-20M 57M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+36.15% upside

Dividenden
By Acuity
Volgende Winsten	7 aug 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-91M 1.8B
Vorige openingsprijs	79.72
Vorige sluitingsprijs	79.09

Nieuwssentiment

By Acuity

14%

86%

19 / 340 Rangschikking in Healthcare

ANI Pharmaceuticals Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

3 aug 2026, 19:46 UTC

ANI Pharmaceuticals is trading higher since Friday's close, despite a flat overall session. The stock remains near the lower end of its one-month range.

31 jul 2026, 20:06 UTC

ANI Pharmaceuticals Inc. shares are declining amid unusual volatility, with trading lower since Thursday as inflation concerns rise alongside US Treasury yields and crude oil prices.

30 jul 2026, 20:09 UTC

ANI Pharmaceuticals Inc. shares are lower during Thursday's session, following a notable dip in late morning trading amid mixed economic signals impacting broader market conditions.

29 jul 2026, 19:19 UTC

ANI Pharmaceuticals shares are higher, rebounding after an earlier pullback. Market sentiment is influenced by expectations for the Federal Reserve's monetary policy announcement today.

28 jul 2026, 20:02 UTC

ANI Pharmaceuticals is advancing today, continuing an upward trend since Monday, despite declines in broader market sectors, particularly technology stocks in Asia.

24 jul 2026, 20:06 UTC

News

ANI Pharmaceuticals shares are lower today amid mixed market sentiment for healthcare stocks. The company plans to discuss its Q2 2026 financial results on August 7, 2026.

22 jul 2026, 20:01 UTC

News

Shares of ANI Pharmaceuticals are lower amid concerns over potential tariffs on imported generic drugs. The stock is near the lower end of its one-month range.

21 jul 2026, 20:12 UTC

ANI Pharmaceuticals Inc. shares are lower in after-market trading, positioned below the 20-day moving average and near the lower end of their one-month range.

20 jul 2026, 19:46 UTC

News

Social Media

ANI Pharmaceuticals shares are lower despite positive results from the Phase 4 SYNCHRONICITY trial, which may support expanded use of ILUVIEN.

Peer Vergelijking

Prijswijziging

ANI Pharmaceuticals Inc Prognose

Koersdoel

By TipRanks

36.15% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 109 USD 36.15%

Hoogste 124 USD

Laagste 91 USD

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor ANI Pharmaceuticals Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

6 ratings

Buy

Hold

Sell

Gebaseerd op 6 analisten die aandelenratings hebben gegeven aan ANI Pharmaceuticals Inc - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

19 / 340 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over ANI Pharmaceuticals Inc

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.